The import value of pharmaceutical goods to the US in 2023 stood at $4.635 billion. The forecasted data indicates a consistent increase in import values: $4.8178 billion in 2024, $4.9986 billion in 2025, $5.1758 billion in 2026, $5.3494 billion in 2027, and $5.5196 billion in 2028. The year-on-year percentage increase is approximately 3.95% for 2024, 3.75% for 2025, 3.55% for 2026, 3.36% for 2027, and 3.18% for 2028. The compound annual growth rate (CAGR) over five years from 2024-2028 is forecasted to be around 3.56%.
Future trends to watch for in the pharmaceutical import market include demographic shifts leading to higher healthcare demand, technological advancements, trade policy changes, and global production shifts influenced by geopolitical factors. These elements will play crucial roles in shaping the trajectory of pharmaceutical imports to the US.